Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gelbrich

Showing results (221-230 of 243) with videos related to

Pageof 25
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 6, 2011
Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart FailureC Zugck, J Franke, G Gelbrich, et al.
International Journal of Cardiology|November 5, 2013
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trialFrank Edelmann, Götz Gelbrich, André Duvinage, et al.
Herz|July 15, 2016
[Assessment of subjective physical well-being in heart failure : Validation of the FEW16 questionnaire]D Jahandar Lashki, C Zelenak, E Tahirovic, et al.
European Journal of Heart Failure|November 25, 2010
Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study designFriedrich Koehler, Sebastian Winkler, Michael Schieber, et al.
Cancer Immunology, Immunotherapy : CII|July 29, 2018
High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T<sub>reg</sub> depletionMario Löhr, Benjamin Freitag, Antje Technau, et al.
JACC. Heart Failure|December 20, 2015
Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD TrialFrank Edelmann, Lindy Musial-Bright, Goetz Gelbrich, et al.
Inorganic Chemistry|April 19, 2007
Tuning the selectivity/specificity of fluorescent metal ion sensors based on N2S2 pyridine-containing macrocyclic ligands by changing the fluorogenic subunit: spectrofluorimetric and metal ion binding studiesM Carla Aragoni, Massimiliano Arca, Andrea Bencini, et al.
JAMA|July 2, 2016
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical TrialChristiane E Angermann, Götz Gelbrich, Stefan Störk, et al.
Cardiology Journal|August 31, 2013
Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD)Svetlana Apostolovic, Dragana Stanojevic, Mitja Lainscak, et al.
JAMA|February 28, 2013
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trialFrank Edelmann, Rolf Wachter, Albrecht G Schmidt, et al.
Pageof 25

Showing results (221-230 of 243) with videos related to

Sort By:
Pageof 25
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 6, 2011
Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart FailureC Zugck, J Franke, G Gelbrich, et al.
International Journal of Cardiology|November 5, 2013
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trialFrank Edelmann, Götz Gelbrich, André Duvinage, et al.
Herz|July 15, 2016
[Assessment of subjective physical well-being in heart failure : Validation of the FEW16 questionnaire]D Jahandar Lashki, C Zelenak, E Tahirovic, et al.
European Journal of Heart Failure|November 25, 2010
Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study designFriedrich Koehler, Sebastian Winkler, Michael Schieber, et al.
Cancer Immunology, Immunotherapy : CII|July 29, 2018
High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T<sub>reg</sub> depletionMario Löhr, Benjamin Freitag, Antje Technau, et al.
JACC. Heart Failure|December 20, 2015
Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD TrialFrank Edelmann, Lindy Musial-Bright, Goetz Gelbrich, et al.
Inorganic Chemistry|April 19, 2007
Tuning the selectivity/specificity of fluorescent metal ion sensors based on N2S2 pyridine-containing macrocyclic ligands by changing the fluorogenic subunit: spectrofluorimetric and metal ion binding studiesM Carla Aragoni, Massimiliano Arca, Andrea Bencini, et al.
JAMA|July 2, 2016
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical TrialChristiane E Angermann, Götz Gelbrich, Stefan Störk, et al.
Cardiology Journal|August 31, 2013
Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD)Svetlana Apostolovic, Dragana Stanojevic, Mitja Lainscak, et al.
JAMA|February 28, 2013
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trialFrank Edelmann, Rolf Wachter, Albrecht G Schmidt, et al.
Pageof 25